pain due to diagnostic laparoscopy. Female infertility
Conditions
Interventions
Intervention 1: In the study group(n=50) 40mL of 0. 25% bupivacaine with 100 µg fentanyl is infiltrated intraperitonealy at the end of operation. Intervention 2: In the placebo group(n=50) 40 ml norma
Treatment - Drugs
In the study group(n=50) 40mL of 0. 25% bupivacaine with 100 µg fentanyl is infiltrated intraperitonealy at the end of operation.
In the placebo group(n=50) 40 ml normal saline is infiltrated intraperitonealy at the end of operation.
Sponsors
Vice Chancellor for Research, Tabriz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Patients scheduled for diagnostic gynecologic laparoscopy; patients aged 18–40 yr; patients with ASA class I or II. Exclusion criteria: Patients with a history of allergy to local anesthetics; patients with a history of systemic disease or psychological disorders; patients with a history of chronic pain syndrome; Patients with a history of NSAIDS or any other analgesic consumption.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: PACU, every 1 hour until 4 hours and then every 4 hours until 24 hours after operation. Method of measurement: Visual analogue scale (VAS) from 0 (without pain) to 10 (severe and intolerable pain). | — |
Secondary
| Measure | Time frame |
|---|---|
| Dose of analgesic requirements. Timepoint: PACU, every 1 h until 4 h and then every 4 h until 24 h after operation. Method of measurement: Injection number and injection dose in mg. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Simin Atashkhoyi
Tabriz University of Medical Sciences
Outcome results
None listed